Prestige Consumer Healthcare Inc. (PBH): A Top Ariel Investments Stock to Buy Following Breathe Right Brand Acquisition

Prestige Consumer Healthcare Inc. (NYSE:PBH) is one of the top stocks to buy according to Ariel Investments. On June 15, Prestige Consumer Healthcare Inc. (NYSE:PBH) completed the acquisition of the Breath Right brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion.

Source: Unsplash

The acquisition aligns with the company’s disciplined merger-and-acquisition framework and is expected to enhance the portfolio over the long term. The Breathe Right brand becomes the company’s largest brand with revenue of about $200 million and core profit of $95 million in 2025.

The acquisition expands Prestige Consumer Healthcare’s portfolio by providing drug-free nasal strips for consumers with better breathing needs. It also boasts established brands with loyal consumer followings, such as Dimetapp, a trusted children’s cough and cold relief brand.

While the brand is mostly distributed in the US, it boasts a leading position in the category with further growth opportunities internationally.

Prestige Consumer Healthcare Inc. (NYSE:PBH) is the largest independent provider of over-the-counter (OTC) healthcare products in North America. The company develops, markets, and distributes a wide variety of familiar brand-name consumer health products—such as Monistat, Breathe Right, Dramamine, and TheraTears—found in pharmacies and retail stores.

READ NEXT: 9 Best Energy Dividend Stocks to Invest In Now and 10 Best Dividend Aristocrat Stocks To Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.